GlassScriptPhysician profile
Jason Jonathon Sico
NPI 1205010493
$10,244.12
in general payments reported to CMS, 2019-2025
4 companies · $10K in 2025
The $10K reported for 2025 was more than what 93% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $26.38 · 2024: $97.78 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,238 · Honoraria: $3,955 · Travel and Lodging: $790 · Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,238.00 |
| Honoraria | $3,955.00 |
| Travel and Lodging | $789.88 |
| Food and Beverage | $234.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $6,105.33 | 2025 | |
| H. Lundbeck A S | $4,014.63 | 2025 | Vyepti |
| Lundbeck LLC | $97.78 | 2024 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $26.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Sico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.